BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17687174)

  • 1. Gene therapy for oral squamous cell carcinoma: an overview.
    Saraswathi TR; Kavitha B; Vijayashree Priyadharsini J
    Indian J Dent Res; 2007; 18(3):120-3. PubMed ID: 17687174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for the treatment of oral squamous cell carcinoma.
    Xi S; Grandis JR
    J Dent Res; 2003 Jan; 82(1):11-6. PubMed ID: 12508038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in the management of oral cancer: review of the literature.
    Ayllón Barbellido S; Campo Trapero J; Cano Sánchez J; Perea García MA; Escudero Castaño N; Bascones Martínez A
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E15-21. PubMed ID: 18167474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [p53 gene therapy for oral cancer].
    Liu SX; Hu M
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Sep; 47(9):569-72. PubMed ID: 23141735
    [No Abstract]   [Full Text] [Related]  

  • 5. Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector.
    Fukui T; Hayashi Y; Kagami H; Yamamoto N; Fukuhara H; Tohnai I; Ueda M; Mizuno M; Yoshida J
    Oral Oncol; 2001 Apr; 37(3):211-5. PubMed ID: 11287273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
    Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
    Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for oral cancer: efficient delivery of a 'suicide gene' to murine oral cancer cells in physiological milieu.
    Young M; Overlid N; Konopka K; Düzgünes N
    J Calif Dent Assoc; 2005 Dec; 33(12):967-71. PubMed ID: 16454240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of ionizing radiation and expression of a wild type p53 gene via recombinant adenovirus induced a prominent tumour suppressing effect in human oral squamous cell carcinoma.
    Wakasa T; Inoue T; Kawai N; Murakami J; Kishi K; Fukui K
    Br J Radiol; 2002 Aug; 75(896):657-62. PubMed ID: 12153939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell lines.
    Fukuhara H; Hayashi Y; Yamamoto N; Fukui T; Nishikawa M; Mitsudo K; Tohnai I; Ueda M; Mizuno M; Yoshida J
    Oral Oncol; 2003 Sep; 39(6):601-9. PubMed ID: 12798404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient nonviral gene therapy with FasL and Del1 fragments in mice.
    Kitano H; Mamiya A; Kokubun S; Hidai C
    J Gene Med; 2012 Nov; 14(11):642-50. PubMed ID: 23136083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoma of the oral cavity].
    Neiger M
    Helv Chir Acta; 1984 Jan; 50(5):535-40. PubMed ID: 6706662
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous malignant melanoma and squamous cell carcinoma of the oral cavity: a case report.
    Nakahara H; Kitamura R; Shirasuna K
    J Oral Maxillofac Surg; 1995 Dec; 53(12):1455-7. PubMed ID: 7490657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer.
    Sewell DA; Li D; Duan L; Westra WH; O'Malley BW
    Arch Otolaryngol Head Neck Surg; 1997 Dec; 123(12):1298-302. PubMed ID: 9413357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of management for oral cavity squamous cell carcinoma (SCC) 1988.
    Collins S
    Ill Dent J; 1988; 57(5):340-1. PubMed ID: 3248797
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on squamous carcinoma of the oral cavity, oropharynx, and maxillary sinus.
    Lubek JE; Clayman L
    Oral Maxillofac Surg Clin North Am; 2012 May; 24(2):307-16, x. PubMed ID: 22341511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].
    Zbären P
    Ther Umsch; 1998 Jul; 55(7):449-52. PubMed ID: 9702117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the oral cavity. Selective management according to site and stage.
    Berktold RE
    Otolaryngol Clin North Am; 1985 Aug; 18(3):445-50. PubMed ID: 4047666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].
    Wolfensberger M
    HNO; 1988 Jan; 36(1):28-32. PubMed ID: 2832353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.
    Yu D; Wang A; Huang H; Chen Y
    Nanomedicine (Lond); 2008 Dec; 3(6):813-21. PubMed ID: 19025455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the efficacy of different regimens of treating patients with cancer of the organs of the oral cavity].
    Kitsmaniuk ZD; Choĭnzonov EL
    Stomatologiia (Mosk); 1988; 67(4):44-6. PubMed ID: 3188101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.